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MalignantAbstract Purpose: Our aim was to evaluate the diagnostic potential of diffusion-weighted mag-
netic resonance imaging (DW-MRI) and quantitative assessment of apparent diffusion coefficient
(ADC) value for the characterization of renal lesions and differentiation into benign and malignant.
Patients and methods: A total of 87 consecutive patients with 107 renal lesions were enrolled in this
prospective study. MRI examinations including DWI with b factors of 0, 600 and 800 s/mm2 were
performed at 1.5 T MRI unit. The mean ADC values of normal renal parenchyma, solid and cystic
lesions were calculated.
Results: There was statistical significance difference between ADC value of normal renal
parenchyma with that of benign (n= 60, 56%) and malignant (n= 47, 44%) renal lesions
(P value < 0.0001). ADC values differed significantly between solid (n= 74, 69.2%) and cystic
lesions (n= 33, 30.8%) (P value < 0.0001). There was significant difference between ADC values
of all benign (n= 60, 56%) and malignant renal lesions (n= 47, 44%) (P value < 0.0001) but
not between benign solid (n= 27, 36.5%) and malignant solid renal lesions (n= 47, 63.5%)
(P value = 0.784).
Conclusion: There is overlap between the ADC values of benign and malignant lesions. The use of
ADC value alone may lead to inaccurate assessment of renal lesions. Thus, DW-MRI should be
interpreted in conjunction with conventional MRI sequences to allow for better characterization
of renal lesions.
 2015 The Authors. The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting
by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.
org/licenses/by-nc-nd/4.0/).1. Introduction
Accurate assessment of renal masses is important for establish-
ing whether tumors require surgical intervention or not. Com-
puted tomography (CT) and magnetic resonance imaging
(MRI) are the primary investigative tools for diagnosing,
326 S. Emad-Eldin et al.characterizing, and staging cystic or solid renal masses
discovered incidentally by ultrasonography (1). However,
MRI further characterized a large proportion of renal masses
that were considered indeterminate at CT (2).
Diffusion weighted magnetic resonance imaging (DW-
MRI) is a reasonable alternative to conventional cross sec-
tional imaging to detect and characterize focal renal lesions,
especially in patients with impaired renal function (3). The dif-
fusion characteristics can be measured objectively and are rep-
resented in the form of apparent diffusion coefficient (ADC)
values. So tissue diffusivity and, hence, diffusion-weighted
imaging (DWI) can provide crucial diagnostic information
regarding the architecture of various tissues and organs (4).
The aim of this study was to evaluate the diagnostic poten-
tial of DW-MRI and quantitative assessment of ADC value
for the characterization of renal lesions and differentiation into
benign and malignant.
2. Patients and methods
2.1. Patients
The studywas approvedby thehospital ethical committee, and an
informed consent was obtained from all patients. During 2 years
duration, we prospectively evaluated 87 consecutive patients
(41 females, 46 males). They ranged in age from 15 to 71 years
(mean 49.86 ± 15.82 year). All patients underwent renal MR
imaging which included DWI for further evaluation and charac-
terization of renal lesions previously detected by US and/or CT.
2.2. Methods
The MRI examinations were performed with a 1.5-T MRI
system using two different MRI machines (Intera and
Achieva; Philips Medical Systems, the Netherlands) equipped
with a phased array body coil. For morphologic evaluation
of the kidneys, respiratory triggered axial and coronal
T2-weighted FSE sequences, axial T2-weighted spectral pre-
saturation with inversion recovery (SPIR) with fat suppression
was initially performed, followed by axial T1-weighted SE, and
T1-weighted dual-echo in-phase and out-of-phase sequences.
A bolus of 0.1 mmol/kg of gadopentetate dimeglumine-
DTPA (Magnevist; Schering, Berlin, Germany) was injected
intravenously followed by 20-mL saline flush. Three-
dimensional fat-saturation T1-weighted dynamic contrast-







1-Axial T1 SE 425/15 90 7–8





4-Axial T2 TSE 4360/95 90 7
5-Axial T2 SPAIR 2000/80 90 7
6-Axial T1 3D GRE 3.4/1.7 10 6
7-DWI-B value 0, 600, 800 1500/80 90 6
TSE, turbo spin echo; GRE, gradient recalled echo; DW, Diffusion-weigrespiration at baseline (pre-contrast), during the arterial phase,
and 30 and 120–240 s after the arterial phase. Gadolinium was
not administrated in 6 cases due to impaired renal function.
MRI imaging protocol is demonstrated in Table 1.
Axial DWI was obtained by using a single-shot spin echo-
planar sequence prior to the administration of contrast mate-
rial. DWI was acquired with b value of 0, 600 and 800 s/mm2.
2.3. Image analysis
All MRI images were transferred to an independent worksta-
tion (Philips MR extended workspace, software version
2009). Image interpretation and diagnosis were carried out
by two radiologists (11 and 15 years experience in abdominal
MRI imaging). After interpretation by Radiologist 1, Radiol-
ogist 2 confirmed the diagnosis, and in case of controversy,
they discussed to reach a consensus.
First the conventionalMRI images, includingun-enhancedand
contrast enhanced images were reviewed. The morphological fea-
tures of each lesion were recorded including number, site, size,
shape, together with signal characteristics, and enhancing pattern.
Based on conventional MRI findings, renal lesions were
divided into solid and cystic groups. Cystic renal lesions
were classified according to the Bosniak classification system
(I, II, II F, III and IV), and Bosniak category IV lesions were
evaluated in the solid group (5,6).
The DWI images, including the images obtained with b val-
ues of 0, 600, and 800 s/mm2, were reviewed together. ADC
values were measured for b value of 800 s/mm2 by using cir-
cumferential region of interest (ROI). Necrotic portions or
lesion margins were excluded from the ROIs. At least three
measurements were performed and the lowest value was
recorded for each b value. Circular ROIs were placed in the
normal renal parenchyma (at the central portion of the kidney)
for the measurement of ADC values.
2.4. Standard of references
The findings obtained using conventional MRI and DWI were
compared with the results of the histopathological findings,
clinical and imaging follow-up.
2.5. Statistical analysis
All statistical calculations were performed using SPSS software






1–2 1 – 350  275
1–2 2 yes 360  140
– 1 – 350  275
– 1 – 350  275
1–2 1 – 350  275
1–2 1 yes 350  275
– 1 yes 350  275
– 4 yes 190  115
hted; TE, echo time; TR, repetition time.
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using Student’s-t-test. Standard diagnostic indices including
sensitivity, specificity, positive predictive value (PPV), negative
predictive value (NPV) and diagnostic efficacy were calculated.
Receiver operating characteristic (ROC) curves were drawn to
find out the area under the curve (AUC) for differentiation of
two groups and cutoff ADC values were calculated in-order to
achieve the highest average sensitivity and specificity. P value
less or equal to 0.05 was considered significant and less than
0.01 was considered highly significant.3. Results
3.1. Lesions characteristics
107 lesions in 87 cases were evaluated in the study. The
final diagnoses of renal lesions included the following:
RCC (n= 35, 32.7%), TCC (n= 3, 2.8%), lymphoma
(n= 8, 7.5%), plasmacytoma (n= 1, 0.9%), Angiomy-
olipoma (AML) (n= 13, 12.1%), pyelonephritis (n= 10,
9.3%), pseudo-tumor in chronic kidney disease (CKD)
(n= 4, 3.7%); Bosniak (Type I) cyst (n= 22, 20.5%), Bosniak
(Type II & II F) cyst (n= 9, 8.4%), and Bosniak (Type III)
cyst (n= 2, 1.8%).
A total of 49 lesions (45.8%) were confirmed by pathology.
Thirty-seven patients underwent radical resection, 3 patients
underwent nephron-sparing surgery, and 9 lesions were con-
firmed by biopsy. The rest of the lesions had been followed
up. They were stable over a minimum period of 6 months on
US or CT examinations. Lesions characteristics are summa-
rized in Table 2.
3.2. Conventional MRI
There were 74 (69.2%) solid lesions and 33 (30.8%) cystic
lesions. Two lesions of Bosniak type IV cysts were classified
in the solid group. Out of 60 benign lesions 33 were cystic
(58.92%) and 27 were solid (39.28%). All 47 malignant renal
lesions were solid.
The signal intensity of the lesions on T1, T2WI and fat-
suppression T1 images was recorded. On T1WI, 75 lesions
(70.1%) elicited low signal, 3 lesions (2.8%) (hemorrhagicTable 2 Lesions characteristics of the study group (n= 107).
Diagnosis No of patients No and % o
Cystic lesions 31 33(30.8%)
–Bosniak I 20 22(20.5%)
–Bosniak II, IIF 9 9(8.4%)
–Bosniak III 2 2(1.8%)







–Pseudotumor in CKD 2 4(3.7%)
Total 87 107cysts) elicited high signal and 29 lesions (27.1%) (10 RCC,
13 AML, 6 hemorrhagic cysts) elicited mixed high and low
signal.
13/32 high T1 signal intensity lesions showed signal drop at
T1 fat-suppression sequence, and they were diagnosed as
AML. 3/32 high T1WI lesions and 16/32 mixed high and
low T1 signal intensities lesions showed no suppression in hem-
orrhagic cysts and masses.
21/35 (60%) RCC lesions, showed heterogeneous enhance-
ment pattern. In such lesions, ROI was placed at the solid
enhancing portion in order to measure the cellular part of
the tumor.
3.3. Diffusion imaging and ADC value
The ADC values of normal renal parenchyma and renal
lesions are listed in Table 3.
There was statistical significance difference between ADC
value of normal renal parenchyma with that of benign and
malignant renal lesions (P value < 0.0001).
ADC values differed significantly between solid (74/107,
69.2%) and cystic lesions (33/107, 30.8%) (P value
<0.0001). There was a significance difference between ADC
values of all benign (60/107, 56%) and malignant renal lesions
(47/107, 44%) (P value <0.0001) but not between benign solid
(27/74, 36.5%) and malignant solid renal lesions (47/47,
63.5%) (P value = 0.784) (Table 4).
The highest ADC value of all lesion was that of Bosniak I
cysts (n= 22). Their ADC value ranged from 2.66 to
3.90  103 mm2/s (mean 3.1 ± 0.53). There were 9 hemor-
rhagic cysts (Bosniak II, IIF), and their ADC value ranges
from 0.63 to 2.31  103 mm2/s (mean 1.51 ± 0.56). We have
2 (Bosniak III) cysts, and their ADC values are 2.01 and
2.22  103 mm2/s. There was a significant difference between
the ADC values of Bosniak I simple cysts and ADC of Bosniak
II and II F hemorrhagic cysts (P value <0.001).
The ADC value of RCC lesions (n= 35) ranged from 1.01
to 1.88  103 mm2/s (mean 1.42 ± 21) (Figs. 1 and 2). The
mean ADC values of TCC (n= 3) and lymphoma lesions
(n= 8) were statistically lower than those of RCC.
3/6 patients diagnosed with AMLs have tuberous sclerosis.
ALL 13 AML lesions are fat containing, and their ADC values
ranged from 0.47 to 1.6  103 mm2/s (mean 0.95 ± 0.29).f lesions Mean size in cm Confirmed by pathology
3.2 ± 0.8 –
4.6 ± 2.1 –
11.5 ± 10.6 2
6.32 ± 3.4 35
3.9 ± 1.73 3
2.6 ± 0.8 8
18 1
3.2 ± 2.5 –
4.06 ± 1.7 –
4 ± 0.3 –
49
Table 3 Apparent diffusion coefficient (ADC) values of different groups in the study.
Study group No Minimum ADC value Maximum ADC value Mean ADC value
Normal renal parenchyma 85 1.6 2.7 2 ± 0.16
Cystic lesions 33
–Bosniak I 22 1.92 4.08 3.11 ± 0.54
–Bosniak II, IIF 9 0.63 2.31 1.51 ± 0.56
–Bosniak III 2 2.01 2.22 2.11 ± 0.14
Solid lesions 74
–RCC 35 1.01 1.88 1.42 ± 0.22
–TCC 3 1.11 1.18 1.15 ± 0.3
Plasmacytoma 1 1.12
–Lymphoma 8 0.58 1.21 0.75 ± 0.2
–AML 13 0.47 1.6 0.95 ± 0.3
–Pyelonephritis 10 0.8 1.42 1.11 ± 0.3
–Pseudotumor in CKD 4 2.5 2.66 2.59 ± 0.6
Table 4 Comparison between mean ADC values of different
groups of the study.
Normal renal parenchyma Benign P value
2 ± 0.16 2.09 ± 1.03 <0.0001*
Normal renal parenchyma Malignant
2 ± 0.16 1.3 ± 0.32 <0.0001*
All benign Malignant
2.00 ± 1.03 1.28 ± 0.32 <0.0001*
Benign solid Malignant
1.25 ± 0.628 1.28 ± 0.32 0.79
Cystic Solid
2.62 ± 0.89 1.27 ± 0.45 <0.0001*
Bosniak I cyst Bosniak II & IIF cyst
3.11 ± 0.54 1.51 ± 0.56 <0.0001*
RCC TCC
1.42 ± 0.22 1.15 ± 0.3 <0.05
RCC Lymphoma
1.42 ± 0.22 0.75 ± 0.2 <0.0001*
RCC AML
1.42 ± 0.22 0.95 ± 0.3 0.0004*
RCC PN
1.42 ± 0.22 1.11 ± 0.3 0.0004*
RCC Pseudo-tumor CKD
1.42 ± 0.22 2.59 ± 0.6 <0.0001*
Data are expressed as mean ± SD. **p< 0.01 = highly significant.
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ADC value ranged from 0.8 to 1.42  103 mm2/s (mean 1.1
± 0.26) (Fig. 3).
ThemeanADCvalue for pseudo-tumors inCKD (n= 4)was
2.6 ± 0.06  103 mm2/s. It was significantly higher than that of
RCC (P< 0.0001) as well as normal renal parenchyma (Fig. 4).
3.4. ADC cutoff value for differentiating benign from malignant
lesions
ROC analysis revealed AUC= 0.758%, 95% CI: 0.668–0.849,
p= 000 at an ADC cutoff value of 61.88  10 mm2/s,sensitivity and specificity for diagnosis of malignant were
100% and 48.3% respectively (Fig. 5).
4. Discussion
DW-MRI has a rising role in the characterization of renal
masses (7). In biologic tissues that are highly cellular (such
as tumors), the higher density of cell membranes restricts the
diffusion of water protons. This restriction to diffusion mani-
fests as high signal intensity on DWI and corresponding lower
ADC (8).
In this study, we investigated the diagnostic potential of
DWI and quantitative assessment of ADC value for the char-
acterization of renal lesions and differentiation into benign and
malignant.
There is no consensus regarding the optimal b-values to
be used in renal imaging (9). An image of low b-value
(0–300 s/mm2) has higher SNR, less distortion, but less dif-
fusion weighting. Conversely, high b-factor (800 s/mm2)
images have more diffusion weighting but suffer from low
signal-to-noise ratio and image distortion. Some researchers
have recommended using b value >400 s/mm2 because it
can reduce ‘‘T2 shine-through’’ and intra-voxel perfusion
effects (10). This study was conducted with b values (0,
600 and 800). Similar b values were used in the previous
reports (10–13).
The main drawback of DWI is the lack of standardization,
and the variability of ADC values is attributed mainly to dif-
ferent sample sizes, b values, coil systems, breath-hold versus
free breathing, and field strengths used for MRI (14).
In normal renal parenchyma we recorded a mean ADC
value of 2.00 ± 0.16  103 mm2/sec). In previous reports,
the mean ADC value of normal renal parenchyma ranged
from 1.72 to 2.65  103 mm2/s (1,15–17).
We found a significant difference in the mean ADC
between malignant and benign renal lesions (P value
< 0.0001). This was in concordance with previous studies
(18–20).
The cutoff ADC value obtained and used for differentiation
between benign and malignant lesions was 1.88  103 mm2/s.
It revealed a sensitivity of 100% and specificity of 48.3%.
Despite the statistically significant difference in the mean
Fig. 1 A 52-year-old female with clear cell RCC. (a) Coronal T2WIs and (b) Postcontrast axial T1WIs show large right renal mass
invading the RV and IVC (arrows), (c) DWI at b value of 800 and (d) ADC map show restricted diffusion of the lesion, and the ADC is
1.5  103 mm2/sec.
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overall considerable overlap between the two groups rendering
ADC measurement of lower value in distinguishing benign
from malignant renal lesions. Based on ADC measurement
alone, 29/60 (48.3%) benign cases were falsely diagnosed as
malignant.
RCC can have a varied appearance on DWI owing to dif-
fering degrees of cellularity and elements of necrosis, cystic
change, or hemorrhage. In such complex renal masses, solid
enhancing tumor components demonstrate lower ADC values
than necrotic or cystic regions (12). In the current work, 60%
of RCCs showed heterogeneous restriction of diffusion, with
solid enhancing regions demonstrated moderate restriction
and T2 hyperintense cystic components demonstrated free
diffusion.
Likewise, TCC displays restricted diffusion due to high cel-
lularity; they stand out as areas of bright signal against a back-
ground of suppressed signal within the collecting system and
adjacent normal renal parenchyma on high b-value images
while demonstrating low signal on the corresponding ADC
map (20).
The present study demonstrated that the ADC value of
TCC was significantly lower than for normal renal parench-
yma and RCC (P value < 0.0001, 0.05 respectively). This
was in agreement with Yoshida et al., who reported lower
ADC values in TCC (1.29 ± 0.15  103 mm2/s), when com-
pared with renal parenchyma (2 ± 0.16  103 mm2/s) (21).
Similarly, in a study by Paudyal et al., they have found that
ADC value was significantly higher for RCC than for TCC
(22). Contrasting results have been reported by Sevcencoa
et al., the authors have found no difference in ADC value
between RCC and TCC (23). Similar to our study, because
of the limited number of included TCC, conclusions cannotbe drawn regarding the value of DW-MRI for distinguishing
between RCC and TCC.
Renal lymphoma tends to show diffusion restriction (24).
In these series, 8 lesions were easily seen with high signal on
DWI. They had the lowest ADC values among all malignant
lesions with a mean value of 0.74 ± 0.2  103 mm2/s, which
is in a range of the previously reported values for lymphoma
(0.64 to 0.76  103 mm2/s) (25–27). The usefulness of ADC
value measurement in the diagnosis of renal lymphoma and
differential diagnosis from other hypo-enhancing renal masses
such as papillary or chromophobe RCC, or metastasis has
been suggested by Nguyen and Rakita. Moreover, they have
found that DWI allowed better depiction of multiple lesions
against a suppressed background signal (25).
AML is a common benign renal neoplasm that occurs in
0.3–3% of the population (1). AML is composed of variable
amounts of fat, muscle tissue, and abnormal blood vessels.
These tissues prevent the molecules of water from spreading
freely, and causing a low ADC value (1). The ability to differ-
entiate AMLs is especially urgent in patients with tuberous
sclerosis, since AMLs develop in about 80% of these patients,
and at the same time these patients are at increased risk of
developing RCC (28).
The ADC value of AML is related to its fat content with
gradually decreasing the ADCs of AML with inverse correla-
tion of its fatty content (13,29). Only 13 lesions were diagnosed
as AML in our study, all of them were fat containing AML.
Hence, they were easily recognized on conventional MRI with
typical fat components. Their mean ADC value (0.95
± 0.3  103 mm2/s) was significantly lower than that of
RCC, and our findings were in concordance with previous
studies (11,12,18,19). Contrasting results have been reported
by Kilickesmez et al., (29) who have found that mean ADC
Fig. 2 A 37-year-old male with chromophobe RCC. (a) Post-
contrast axial T1WIs show heterogenous enhancing large exo-
phytic right renal lesion with nonenhancing central region. (b)
DWI at b value of 800 and (c) ADC map show restricted diffusion
of the peripheral solid part and facilitated diffusion of the central
region. The ADC values of the peripheral solid component and
central region are 1.27  03 mm2/sec and 2.8  103 mm2/sec
respectively.
330 S. Emad-Eldin et al.value was higher for AMLs (1.40 ± 0.21) than for RCCs (1.06
± 0.39). Also Inci et al., (1) reported a mean ADC value of
1.19 ± 0.36 for 16 cases of AML, with no significant difference
from RCCs (1.12 ± 0.23).
Renal infection and some associated complications also
demonstrate restricted diffusion and should not be mistakenfor malignancy. Pyelonephritis results in patchy non mass like
areas of restricted diffusion in portions of the renal parench-
yma, a finding that may relate to inflammatory cell infiltration
and possible ischemic effects of infection (30). In this work, 10
lesions were diagnosed as multifocal pyelonephritis. The mean
ADC value of all lesions was 1.11  103 mm2/s ± 0.3, that
was lower than mean ADC of normal renal parenchyma and
RCC with statistical difference. This was in agreement with
the findings of Goyal et al., who have found that the ADC val-
ues of inflammatory lesions were significantly lower than those
of RCC, suggesting that DW-MRI may be an additional tool
to distinguish between inflammatory and malignant renal
lesions (31).
Owing to non-uniform patchy involvement in CKD (32–
34), there may be nodular compensatory hypertrophy of the
relatively spared renal parenchyma, leading to the formation
of pseudo-tumors, which may produce mass effect in the
form of contour abnormality or splaying/compressing the
pelvicalyceal system (35). In our series, the mean ADC
value of four lesions diagnosed as pseudo-tumor was 2.59
± 0.62  103 mm2/s, which was higher than the ADC values
of RCCs (P value < 0.0001). This was in concordance with the
previously reported value of 2.50 ± 0.22  103 mm2/s (35).
As perviously reported by Goyal et al. (35), we have found,
that the surrounding renal parenchyma showed peripheral-
based, wedge-shaped foci of restricted diffusion.
In our study, the highest ADC value of all lesions was that
of simple renal cyst (Bosniak I). This could be attributed to
their fluid content, with non-restricted motion of water mole-
cules (29). Our findings were in concordance with previous
reports (1,11,12,19).
Renal hemorrhagic cysts can sometimes display very low
signal on the ADC map, a finding that may relate to the ‘‘T2
blackout’’ effects of an intrinsically T2 hypointense lesion
and/or restricted diffusion in blood products (36). In this
study, we compared the ADC values of simple renal cyst (Bos-
niak I) and hemorrhagic T1 hyperintense (Bosniak II, IIF)
cysts, to rule out the effect of hemorrhagic content in ADC
values variations. Similar to Sandrasegaran et al. (19), we have
found that the mean ADC value of hemorrhagic cysts was
lower than that of simple cysts, with statistical significant dif-
ference (P value < 0.0001).
In this study, the use of DWI and ADC measurement was
particularly useful in diagnosis of renal lesions of 6 patients
with renal insufficiency in whom contrast medium was not
administrated for the fear of nephrogenic systemic fibrosis.
DWI allowed for better depiction of pyelonephritis and TCC
lesions. Furthermore, it confirmed the diagnosis of pseudo-
tumor in CKD and excluded the possibility of RCC, owing
to lack of diffusion restriction and high ADC value.
Limitations of this study include relatively poor spatial res-
olution and anatomic localization with the use of high b value
DWI, together with small number of patients sample in some
groups such as TCC and plasmacytoma which to some extent
limit the power of statistical analysis.
In conclusion, DWI and quantitative ADC measurements
could be easily added to a routine MR imaging protocol. It
had the advantages of being fast and not requiring a contrast
administration. However, there is an overlap between the
ADC values of benign and malignant lesions. Thus ADC mea-
surement could not predict with certainty if the lesions were
benign or malignant. DW-MRI should be interpreted in
Fig. 3 A 50-year old diabetic male patient with left renal pyelonephritis. Gd-DTPA was not administrated due to impaired kidney
function. (a) Axial fat-suppression T2WI demonstrates enlarged left kidney, showing a well defined cystic lesion with two tiny foci of
subtle hyperintense T2 signal. (b) DWIs at b value 800 and (c) ADC map show marked restricted diffusion of the lesion, with ADC value
of 0.6  103 mm2/sec. Very bright signal on diffusion and dark signal on ADC map are characteristic of renal abscess. The two foci show
diffusion restriction as well, and they are better depicted on ADC images (arrowed).
Fig. 4 A 17-year old female patient with pseudo-tumour in CKD. Gd-DTPA was not administrated owing to impaired kidney function
as a result of Systemic Lupus Erythematosus (SLE). (a) Axial T1WI shows a nodular lesion at the medial aspect of the right kidney mildly
hypointense to surrounding parenchyma. The lesion is hyperintense on axial fat suppression T2WI (b). Note small atrophic left kidney. (c
and d) DWI at b value of 800 and ADC map demonstrate absence of diffusion restriction (ADC value is 2.61  103 mm2/sec). There are
wedge areas of diffusion restriction in the surrounding renal parenchyma.
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Fig. 5 Receiver operating characteristic (ROC) curve of the
cutoff ADC value used for differentiating malignant from benign
renal tumors which is 1.88  103 mm2/sec with an area under the
curve (AUC) = 0.758%.
332 S. Emad-Eldin et al.conjunction with conventional MRI sequences to allow for
better assessment of renal lesions.
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